Keyphrases
Disease Risk
100%
Nanoparticles
100%
Zika Virus
100%
Virus Envelope
100%
Disease Enhancement
100%
Dengue Virus
27%
E Domain
27%
C57BL
18%
Virus-neutralizing Antibody
18%
Zika Virus Infection
18%
STAT2
18%
Antibody-dependent Enhancement
18%
Electron Microscopy
9%
Dynamic Light Scattering
9%
Neurological Abnormalities
9%
Balb C Mice
9%
India
9%
Virus-specific
9%
Specific Antibodies
9%
Immunogenicity
9%
Further Development
9%
Potential Risk
9%
Immunogenic
9%
Vaccine Candidate
9%
Virus Challenge
9%
Human Pathogens
9%
Neutralizing Epitope
9%
Protective Efficacy
9%
Vaccinees
9%
Specific Monoclonal Antibodies
9%
NIAID
9%
Pichia Pastoris
9%
Envelope Protein
9%
Dengue Infection
9%
Severe Dengue
9%
Arbovirus
9%
Sublethal
9%
Scattering Microscopy
9%
Zika Vaccine
9%
Particulate Structure
9%
AG129
9%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
100%
Nanoparticle
100%
Zika Virus
100%
Antibody Dependent Enhancement
18%
Dengue Virus 2
18%
Dengue Virus
18%
Zika Fever
18%
STAT2 Protein
18%
Monoclonal Antibody
9%
Virus Infection
9%
Electron Microscopy
9%
Antibodies
9%
Epitope
9%
Pathogenesis
9%
Virus Antibody
9%
Bagg Albino Mouse
9%
Neutralizing Antibody
9%
Virus Envelope Protein
9%
Immunogenicity
9%
Severe Dengue
9%
Komagataella pastoris
9%
Arbovirus
9%
Zika Virus Vaccine
9%
Light Scattering
9%